DCPH

Deciphera Pharmaceuticals, Inc. Common Stock

Delisted

DCPH was delisted on the 10th of June, 2024.

150 hedge funds and large institutions have $885M invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 59 increasing their positions, 34 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
150
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$8.3M
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$28.5M
2 +$12.9M
3 +$12.4M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$11.5M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$10.5M

Top Sellers

1 -$69.6M
2 -$13.2M
3 -$12.7M
4
AC
Armistice Capital
New York
-$11.7M
5
JG
Jefferies Group
New York
-$9.54M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$336K
102
$328K
103
$320K
104
$267K
105
$264K
106
$257K
107
$239K
108
$221K
109
$207K
110
$206K
111
$203K
112
$202K
113
$200K
114
$198K
115
$196K
116
$185K
117
$168K
118
$124K
119
$114K
120
$90K
121
$84K
122
$76K
123
$69K
124
$61K
125
$53K